Blood filtering for severe liver failure with organ damage
Part of Digestive system clinical trials.
This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a long-term liver condition (like cirrhosis) that suddenly got worse and requires hospital care.
- At least two major organs (such as kidneys, brain, or lungs) are failing because of your liver problem.
- You are age 18 or older.
- You will receive a special blood-filtering treatment called CytoSorb to remove harmful toxins.
- You have not had a sudden, severe liver failure without prior liver disease.
- You do not have advanced heart failure, a recent heart attack, or a severely weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment that cleans your blood to help your liver recover if you have sudden liver failure. It may improve your chances of getting better.
This trial tests a new liver dialysis device called DIALIVE 2.0 for people with acute-on-chronic liver failure (a sudden, severe worsening of chronic liver disease). If you qualify, the device will help filter your blood, similar to kidney dialysis, to support your liver while it tries to recover.
This trial tests whether giving a smaller amount of a blood-cleaning treatment (plasma exchange) can help people with sudden liver failure on top of long-term liver disease. It aims to improve liver function and overall outcomes.
This trial tests a procedure that cleans your blood (called plasma exchange) given at half the usual dose, along with other detox methods, to help people with sudden liver failure. It aims to help your liver recover or support you while you wait for a transplant.
This study looks at new scoring systems to predict how patients with acute-on-chronic liver failure (a sudden worsening of long-term liver disease) will do. It may help doctors better understand and treat this condition.
This trial tests a device called CytoSorb that filters the blood to reduce inflammation in patients with sudden worsening of chronic liver disease. It may help support organ function and recovery.
Hear when a new Acute on Chronic Liver Failure (ACLF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.